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The brown adipose tissue (BAT) evolved as a specialized thermogenic organ in 
mammals. Nutrients (i.e., fatty acids and glucose) from the intracellular storage and 
peripheral tissues are critical to the BAT thermogenic function. The BAT converts 
the chemical energy stored in nutrients to thermo energy through UCP1-mediated 
nonshivering thermogenesis (NST). Activated BAT contributes significantly to 
the whole body energy substrate homeostasis. It is now well-recognized that adult 
humans possess BAT with functional thermoactivity. Thus, BAT energy metabolism 
has a significant therapeutic potential in the management of metabolic disorders, 
such as obesity, insulin resistance, type 2 diabetes, and lipid abnormality in 
humans.
Keywords: brown adipose tissue, brown adipocyte, metabolism, fatty acid,  
glucose, metabolic disorders
1. Introduction
Brown adipose tissue (BAT) evolved as a specialized thermogenic organ in the 
modern eutherian mammals, including Homo sapiens [1–7]. The main function of 
BAT is mediating adaptive thermogenesis or nonshivering thermogenesis (NST), 
when mammals are challenged in the cold environment. The NST function is a criti-
cal adaptation, which helps to maintain the homeothermy in mammals and gives 
them the evolutionary advantage to survive in the cold habitat, and to thrive from 
the Artic to the Antarctic region [3, 4]. During the cold challenge, BAT metabo-
lizes nutrients (i.e., fatty acids and glucose) and converts the chemical energy to 
thermo energy through NST. In addition to its thermogenic function, activated 
BAT also contributes significantly to whole body energy substrate homeostasis. 
When activated, BAT presents physiologically significant benefit in fatty acids and 
glucose homeostasis as well as insulin sensitivity in mammals [8–24]. It is now well-
recognized that adult humans possess BAT, which has functional thermoactivity 
[8–10, 25]. Cold challenge-activated BAT is detected mainly in the supraclavicular, 
paravertebral, and cervical regions in adult humans [9, 10, 25, 26]. Accumulating 
evidences indicate that BAT function is inversely associated with age, body mass 
index (BMI), and diabetic status in adult humans, which indicates that the activa-
tion of BAT has potential translational implication in the management of metabolic 
disorders, such as diabetes and obesity in humans [8–14, 16, 17, 21, 27].
Brown adipocyte, which is endowed with mitochondria, is the most impor-
tant thermogenic functional unit of BAT [4, 28]. In the mitochondrion of brown 
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adipocyte, energy generated from nutrients is initially stored as proton gradient 
membrane potential across the mitochondrial inner membrane, and then con-
verted directly to thermo energy by the uncoupling protein 1 (UCP1)-mediated 
proton flow [4, 29]. In BAT, brown adipocytes are surrounded by abundant capil-
laries. The heat generated in the brown adipocyte mitochondria can be quickly 
distributed by the blood flow to maintain the steady core body temperature in 
mammals [4]. In addition to classical brown adipocytes, beige/brite adipocytes 
can be induced from the white adipocytes to conduct thermogenesis upon the 
cold challenge or catecholamine stimulation [26, 30, 31]. This process is termed as 
“browning” [26, 30, 31]. Thermogenesis in beige/brite adipocytes can also contrib-
ute to mammals’ body temperature maintenance and whole body metabolism [26, 
30, 31]. Beige/brite adipose tissue generates heat through both UCP1-independent 
thermogenesis, including calcium cycling in and out of endoplasmic reticulum, 
futile cycle between creatine and phosphocreatine, and UCP1-dependent thermo-
genesis in mitochondria [26, 30–33]. The energy metabolism is essential for the 
optimal UCP1-mediated mitochondrial thermogenic function of brown and beige/
brite adipocytes [4, 34, 35]. In this chapter, we discuss the importance of energy 
metabolism in maintaining brown adipocyte thermogenic function and the pro-
ceeding of targeting metabolic disorder through BAT activation in human studies.
2. Fatty acid metabolism in brown adipocytes
Thermogenic brown adipocyte possesses a high capacity for fatty acid 
β-oxidation that has been reported in both rodent and humans [4, 12, 14, 36]. Fatty 
acids serve as the activator for UCP1, which is a fatty acid/H+ symporter directly 
mediating proton flow and thermogenesis [37]. Fatty acids also serve as the main 
energy substrate mediating the uncoupling and thermogenic function in brown 
adipocytes [2, 36–41]. In addition, fatty acids can enhance brown adipocyte ther-
mogenic capacity through the nuclear receptor peroxisome proliferator-activated 
receptors (PPARs), which are the master transcription regulators for the expression 
of genes involved in lipid metabolism, oxidative phosphorylation, and the key 
thermogenic protein UCP1 in brown adipocytes [42, 43].
Intracellular fatty acids are stored in the format of triglyceride in the hetero-
geneous multilocular lipid droplets in the brown adipocyte [4]. Upon the cold 
challenge, triglycerides stored in the brown adipocyte lipid droplet are lipolysed. 
Triglyceride lipolysis is a sequential process that involves different enzymes, 
resulting in the liberation of glycerol and fatty acids for heat production [44]. 
The lipid droplet is composed of triglycerides and cholesterol esters, which are 
surrounded by a monolayer of phospholipids [44]. Important proteins with regu-
latory and enzymatic functions, including perilipin and CGI58, coexist on the 
phospholipid monolayer to regulate the lipid trafficking and other functions of 
the lipid droplet [44–47]. Perilipin stabilizes the lipid droplet and prevents it from 
lipolysis under basal condition. Upon cold challenge, β-adrenergic stimulation leads 
to the activation of G-protein-coupled receptor (GPCR) and adenylate cyclase, 
which subsequently increases the cAMP level in brown adipocyte [48]. cAMP 
then activates protein kinase A (PKA), which phosphorylates perilipin at its serine 
residues [49–52]. The phosphorylated perilipin releases CGI-58, an adipose triglyc-
eride lipase (ATGL)-activating protein. CGI-58, subsequently, binds and actives 
ATGL. Activated ATGL hydrolyzes triglycerides and generates free fatty acids and 
diglycerides [50, 53–55]. Upon the cold challenge, PKA also phosphorylates serine 
residues on another key lipolysis enzyme hormone sensitive lipase (HSL) [56]. 
Although HSL is capable of hydrolyzing triglycerides, diglycerides, monoglycerides, 
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and a broad array of other lipid substrate, it is the rate-limiting enzyme for hydro-
lyzing the diglycerides in vivo [56]. The phosphorylated HSL catalyzes the diglyc-
erides and generates free fatty acids and monoglycerides [56]. As the last step of 
lipolysis, monoglycerides is hydrolyzed by monoacylglycerol lipase (MGL) to form 
free fatty acids and glycerol [57].
Given the importance of fatty acid in brown adipocyte thermogenic function, 
it is reasonable to predict that the deficiency of the key lipolysis enzymes and 
fatty acid transportation proteins in brown adipocytes can lead to a defected BAT 
thermogenic function. Human and rodent in vivo studies using both pharmaco-
logical and genetic approaches to manipulate triglyceride lipolysis processes were 
reported [36, 39, 58–60]. In the initial studies, nicotinic acid (NiAc) was used to 
inhibit intracellular triglyceride lipolysis through acting on metabolite-sensing 
Gi-protein-coupled GPR109A and subsequent PKA activation [36, 58, 61]. A study 
in rats suggested the brown adipocyte intracellular lipid lipolysis played a major 
role in thermogenesis in rodents [36]. It showed that the intracellular triglyceride 
lipolysis contributes to 84% of thermogenesis during an acute cold challenge (10°C, 
2–6 hours) and 74% of thermogenesis during a chronic cold challenge (10°C, 
21 days) [36]. The importance of the brown adipocyte intracellular triglyceride-
derived fatty acids was also reported in a human study [58]. In this study, adminis-
trating intracellular triglyceride lipolysis inhibitor NiAc significantly blunted BAT 
oxidative metabolism in cold-challenged young healthy humans (average 30 years 
of age with an average BMI of 24.5 kg/m2). During a 3-hour cold challenge at 10°C, 
NiAc administration suppressed BAT intracellular triglyceride lipolysis by about 
50% and BAT oxidative metabolism by 70%, despite of the increased blood flow in 
the BAT [58].
One caveat from both the aforementioned human and rodent in vivo studies is 
that NiAc-mediated lipolysis inhibition took effect in both brown and white adipo-
cytes in addition to other tissues, which makes it hard to delineate the contribution 
of lipolysis from each cell type. An in vitro study nicely confirmed the importance 
of intracellular lipolysis in brown adipocytes [2]. In cultured primary mouse brown 
adipocytes, the inhibition of both of the key lipolysis enzymes adipose triglyceride 
lipase (ATGL) and hormone-sensitive lipase (HSL) led to a 97% decrease in isopro-
panol-induced brown adipocyte respiration, indicating the imperative requirement 
of intracellular lipolysis in activated brown adipocytes [2]. These studies suggested 
that fatty acids liberated from the intracellular triglyceride storage serve as a critical 
fuel resource and contribute significantly to BAT thermogenesis in brown adipo-
cytes upon activation.
Further studies in genetically manipulated mice showed similar results. The 
ATGL-knockout mouse presented defective triglyceride lipolysis function with 
increased BAT weight (8.5-fold), enlarged lipid droplet (20-fold), and decreased 
BAT explant lipid hydrolysis activity (−85%) [38]. The impaired triglyceride 
lipolysis activity in the ATGL-knockout mouse led to a defective thermogenic func-
tion. Upon a 5-hour 4°C challenge, mouse body temperature dropped to a critical 
low point at around 25°C [38]. Another study using mice with CGI-58 deficiency in 
both white and brown adipocytes also showed decreased BAT thermogenic func-
tion. The adipose-CGI-58-knockout mice were cold-sensitive, but only under fasted 
state [60]. The HSL-null mouse adipose tissue also presented defected triglyceride 
lipolysis function. Upon catecholamine-stimulation, HSL-null adipose tissue 
explants exhibited significantly reduced fatty acid and almost blunted glycerol 
release into the culture medium, parallel with diglycerides accumulation in both 
white and brown adipose tissue [56, 62]. However, it seems that HSL-mediated 
lipolysis function is not as critical as ATGL-mediated lipolysis function in brown 
adipocytes. An in vitro study showed that isopropanol-induced UCP1 activity was 
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largely dependent on ATGL function (80%) compared to HSL function (35%) in 
cultured primary brown adipocytes, and the combined inhibition of both ATGL 
and HSL functions led to an almost complete block of UCP1-mediated thermogenic 
function (97%) [2].
These studies highlight the cardinal role of intracellular triglyceride liberation 
in the brown adipocyte thermogenic function, but raise the question if the brown 
adipocyte intracellular lipolysis is essential for BAT to maintain the adaptive ther-
mogenesis in vivo. Interestingly, recent studies using UCP1-Cre-mediated knockout 
of either ATGL or CGI-58 gene in mice showed an unexpected insignificant impact 
of brown adipocyte intracellular lipolysis and suggested that the circulating fatty 
acids mobilized from peripheral tissues may play more important roles in BAT 
thermogenesis in mice [59, 60]. These studies demonstrated that the loss of either 
ATGL or CGI58-mediated triglycerides lipolysis in brown adipocytes did not 
compromise the cold challenge-induced thermogenic response in mice [59, 60]. The 
phenotypic discrepancy between the systemic and BAT-specific ATGL and CGI-58 
knockout mice brings very important insights to in vivo BAT fatty acid metabolism, 
and indicates that the brown adipocyte intracellular lipolysis is not the only energy 
resource for in vivo adaptive thermogenesis during cold challenge. Although it 
is not clear about the exact partition of intracellular and circulating fatty acids 
contribution to the BAT thermogenic function, it is reasonable to speculate that the 
core body temperature maintenance is vital for mammals to maintain their optimal 
function during the cold challenge, when the intracellular lipolysis function is 
impaired or insufficient, circulating energy substrates from other metabolic tissues, 
that is, white adipose tissue and liver, are mobilized to provide energy substrates for 
BAT-mediated adaptive thermogenesis to maintain the adequate core body tempera-
ture and ensure the optimal functionality of mammals.
Long-chain fatty acids (LCFAs) are the most abundant format of fatty acid 
energy substrate in mammals [63–66]. The liberated LCFAs from intracellular 
lipid droplet are facilitated and transported to mitochondrion and nucleus by 
fatty acid-binding proteins (FABPs) to conduct their functions [67]. Of the six 
FABP isoforms, FABP4 (also termed adipocyte p2) and FABP5 are the major FABP 
isoforms in brown adipocytes [68–74]. Mice mutated in both FABP4 and FABP5 
gene developed severe hypothermia during fasting after an acute cold challenge 
(1–3 hours), indicating that fatty acids transportation plays an indispensable role in 
BAT thermogenic function [74].
The LCFAs-mediated mitochondrial oxidation and UCP-1 activation function 
require sequential carnitine acyltransferases in order to translocate the LCFA into 
mitochondrial matrix. Carnitine palmitoyltransferase 1 (CPT1), located on the 
mitochondrial outer membrane, is the rate-limiting enzyme that mediates LCFAs 
inward translocation into mitochondrial matrix [63–66]. CPT1 exists in tissue-
specific isoforms, and CPT1b is the major isoform expressed in brown adipocytes 
[75–77]. Mouse embryos-carried homozygous knockout of Cpt1b gene were lethal 
before embryonic day 9.5–11.5 and a normal percentage of CPT1b+/− mice was born 
from the CPT1b+/− and wild type breeding pairs [78]. However, more than 50% of 
the CPT1b+/− pups were lost before weaning [78]. The detailed experiment showed 
that ∼7% CPT1b+/− mice developed fatal hypothermia following a 3-hour cold 
challenge (4°C) and ∼52% CPT1b+/− mice developed fatal hypothermia following a 
6-hour cold challenge (4°C), indicating the critical contribution of CPT1b-mediated 
LCFAs transportation and thermogenesis during the cold challenge in infant/young 
mice [78]. Carnitine palmitoyltransferase 2 (CPT2) is located on mitochondrial 
inner membrane to further medicate LCFAs translocation into mitochondrial 
matrix. In line with the study using the CPT1b-deficient mice, an adipose-specific 
CPT2 knockout mice also presented hypothermic phenotype after 3 hours cold 
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challenge (4°C) and decreased LCFAs oxidation in isolated MEF cells [39, 79]. These 
studies indicate that fatty acid transportation is critical for BAT thermogenic func-
tion during the cold challenge.
The intramitochondrial LCFAs contribute to the thermogenesis through UCP-1 
activation and β-oxidation. A detailed study confirmed that mice with impaired 
fatty acid β-oxidation are cold-intolerant [80]. The acyl-CoA dehydrogenases, 
which catalyze the initial steps of fatty acid β-oxidation, are composed of a group 
of enzymes, including very long-chain acyl CoA dehydrogenase (VLCAD), long-
chain acyl CoA dehydrogenase (LCAD), and short-chain acyl CoA dehydrogenase 
(SCAD) [81, 82]. A detailed experiment showed that fetal hypothermia was 
presented in all of the homozygous knockout mice (VLCAD−/−, LCAD−/−, and 
SCAD−/−) after 1-hour 4°C challenge [80]. Although the mice with single heterozy-
gous of VLCAD, LCAD, and SCAD genes were cold tolerate; more than 30% of mice 
with double heterozygous VLCAD+/−//LCAD+/− or LCAD+/−//SCAD+/− and triple 
heterozygous VLCAD+/−//LCAD+/−//SCAD+/− combinations developed hypothermia 
upon the cold challenge [80], indicating the essential role of the LCFAs-mediated 
thermogenic function in mitochondria.
In summary, these studies highlight the importance of the brown adipocyte 
lipolysis and the liberated intracellular fatty acid transportation and oxidation during 
thermogenesis. In addition, these studies indicate that brown adipocytes not only use 
the intracellular lipid storage, but also the circulating energy substrate to maintain 
the critical thermogenic function for the organismal survival and optimal function in 
mammals [2, 12, 38, 44, 56, 59, 60, 80]. In modern days, BAT’s ability to metabolize 
fatty acids mobilized from other peripheral storages, including white adipose tissue 
and liver, makes it a good potential therapeutic target in humans. Studies have shown 
that BAT mediates significant plasma lipid clearance during the cold challenge in 
rodent and humans under both physiological and pathological conditions [83–85].
One study showed that the activated BAT is involved in the basal and post-
prandial triglyceride metabolism in rodents [83]. In this study, compared to mice 
kept at 22°C, mice kept at 4°C had significantly lower triglyceride-rich lipoproteins 
(TRLs)-triglyceride concentration [83]. The study also showed that the activated 
BAT was involved in the post-prandial triglyceride metabolic process, evidenced by 
an oral 3H-triolein tolerance test. Under cold challenge condition, the BAT 3H-triolein 
uptake was significantly higher than that of either liver or skeletal muscle, suggest-
ing the significant triglyceride/triglyceride-rich lipoprotein metabolism in activated 
BAT. For the triglyceride clearance, circulating triglycerides rose to a peak at 2 hours 
postprandial and declined subsequently in mice kept at 22°C. In contrast, the 
triglyceride level reminded persistently low in mice kept at 4°C, suggesting that the 
BAT possesses a high postprandial triglyceride clearance function [83]. Most interest-
ingly, the cold challenge increased the uptake of radio-labeled lipoprotein in BAT and 
reduced the uptake in liver [83]. The cold challenge-induced lipid clearance shift sug-
gests that BAT can be targeted for lipid metabolism in vivo. In a pathological setting, 
the genetically manipulated Apoa5−/− mice with severe hyperlipidemia were studied. 
A 4–24 hours 4°C challenge corrected Apoa5−/− mouse plasma lipid concentration to 
the values comparable to wild-type mice, indicating the significant impact of BAT on 
whole body lipid metabolism in the rodent under the pathological condition  
[83, 86, 87]. Other studies also showed that the BAT preferentially uptook plasma 
triglycerides through peripheral tissue lipolysis, and the selective fatty acids uptake 
from triglyceride-rich lipoprotein ameliorated hyperlipidemia in rodents [84, 85].
Although the studies in rodent strongly support the importance of BAT in lipid 
clearance, the significance of BAT in human lipid metabolism is still unclear. The 
contribution of activated BAT in human body was studied using a dietary radio-
labeled LCFAs tracer 14(R,S)-[18F]-fluoro-6-thia-heptadecanoic acid (18FTHA) [88]. 
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This study showed that a 4-hour mild cold-challenge at 18°C significantly increased 
dietary fatty acids distribution in BAT in humans [88]. However, given the relative 
small volume of BAT tissue, the dietary fatty acids clearance contribution from the 
BAT is less significant compared to other organs including heart, liver, white adipose 
tissue, or skeletal muscles, and only contributed to ~0.3% of total body dietary fatty 
acids clearance upon the mild cold challenge [88]. Similarly, another study using 
fatty acid tracer 18F-fluoro-thiaheptadecanoic acid (18FTHA) showed that a 3-hour 
cold challenge at 18°C led to four times higher radio-labeled tracer uptake and ~80% 
metabolic rate increase in the BAT, contributing <1% of total fatty acids clearance 
rate in human subjects [12]. Nevertheless, these experiments suggest that BAT not 
only exists, but also is functionally active and can contribute to systemic metabolism 
in humans. One possible reason for the relatively low BAT contribution in fatty acids 
metabolism in humans could be due to the short cold challenge time and mild cold 
challenge conditions. It is possible that during the acute cold challenge, intracellular 
lipid lipolysis serves as the main energy resource so that it ameliorates the clearance 
of circulating TRLs or fatty acids.
The circulating TRLs or fatty acids are transported into brown adipocyte by 
a group of proteins, including lipoprotein lipase (LPL) and fatty acid transport 
proteins [83, 89–93]. LPL is a multifunctional protein produced by many tissues, 
including the adipose tissue [94]. LPL serves as a rate-limiting enzyme mediating 
extracellular lipolysis [94]. It hydrolyzes triglycerides into lipid-rich proteins into 
fatty acids and monoacylglycerol. It also mediates the cellular uptake of triglyceride 
and other lipids [94]. Studies have shown that cold challenge or catecholamine-
stimulation induce the expression and activity of LPL in brown adipocytes through 
a cAMP-mediated mechanism [89–91]. After activation, LPL is released from the 
brown adipocyte, transferred to the capillary endothelium lumen, and serves as 
the anchor between the endothelium cell surface and the TRLs [95–97]. Next, the 
LCFAs liberated from LPL channel into brown adipocyte for thermogenic func-
tion [98, 99]. A study indicated that the local LPL activity is required for TRLs 
uptake into the BAT [83]. In this study, it is shown that either LPL-specific inhibitor 
tetrahydrolipstatin pretreatment or releasing LPL from endothelium by heparin 
significantly blocked the uptake of TRL and fatty acids in BAT [83].
The liberated LCFAs in circulation can be transported into cells and activated 
by both transmembrane fatty acid transporter proteins (FATPs) and scavenger 
receptor CD36 [92, 93]. FATPs are composed by a family of six proteins mediating 
circulating LCFAs uptake and distribution in cells [83, 92, 93, 100]. Among the 
six isoforms, FATP1 (SLC27A1) is the major isoform in brown and white adipose 
tissue [83, 92, 93, 100]. Studies showed that postprandial lipid uptake is highly 
dependent on the adipose tissue FATP1 [101]. The FATP1-knockout mice have 
decreased lipid uptake in adipose tissue and a compensatory lipid redistribution 
in liver and heart, where FATP1-mediated lipid uptake function is not required 
under normal conditions [101]. The cold challenge can induce FATP1 expression 
in BAT [100]. In line with this, the isolated FATP1-null brown adipocytes showed 
significantly less fatty acids uptake upon catecholamine stimulation [100]. In vivo 
studies showed that in cold challenged FATP1-knockout mice, BAT triglyceride 
storage was decreased and circulating serum free fatty acids was increased, 
indicating the importance of FATP1-mediated fatty acid uptake in BAT [100]. 
The LCFAs uptake can also be mediated by the transmembrane class B scavenger 
receptor CD36 [83, 102, 103]. Upon the cold challenge, CD36 is significantly 
upregulated in adipocytes [83, 102]. Other studies using CD36−/− mice clearly indi-
cated the importance of CD36-mediated LCFAs transportation during thermogenesis. 
Around 60% of Cd36−/− mice died during a 24-hour cold challenge, which is paralleled 
with drastically increased plasma free fatty acids concentration [83, 102]. A recent 
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study indicated that CD36-medicated coenzyme Q (CoQ ) uptake is required for 
the BAT mitochondrial thermogenic function [104].
In summary, fatty acid is indispensable for the brown adipocyte thermogenic 
function. Fatty acid mediates brown adipocyte thermogenesis through mitochon-
drial β-oxidation, UCP1-activation, and fatty acid-mediated thermogenic gene 
regulation. Both the intracellular fatty acids from brown adipocyte lipolysis and the 
liberated fatty acids from peripheral tissues play essential roles mediating the criti-
cal BAT adaptive thermogenic function to main the adequate core body temperature 
in mammals. In modern days, activating BAT thermogenic function to increase fatty 
acids uptake and utilization may offer new therapeutics to treat human metabolic 
disorders.
3. Glucose metabolism in BAT
The radio-labeled glucose analog 18F-fluorodeoxyglucose (18F-FDG), in combi-
nation with positron emission tomography (PET) and computed tomography (CT), 
provides a reliable method for the in vivo tissue glucose uptake study [105, 106]. 
Based on studies using this method, it is now well-recognized that BAT in both 
rodents and humans possesses a significant glucose uptake capacity upon the cold 
challenge [4, 9–12, 25, 26, 107–112].
Glucose uptake is regulated in brown adipocytes. In vivo studies showed that 
cold challenge significantly enhanced insulin sensitivity and subsequent glucose 
uptake in the BAT [9, 10, 25, 26, 107, 112, 113]. Interestingly, other studies showed 
that starved rats with low insulin level also had increased BAT glucose uptake dur-
ing the cold challenge, indicating that the enhanced glucose uptake is not com-
pletely insulin-dependent [114]. Additional studies also indicated that the enhanced 
glucose uptake in brown adipocytes can be mediated by different pathways in 
addition to insulin stimulation, including β-adrenergic receptor activation, AMP-
activated protein kinase (AMPK) activation, and mTOR activation [115–117].
The importance of glucose metabolism in BAT is a long-standing question. 
Glucose transporters, which facilitate glucose across the cell plasma membrane is 
the first rate-limiting step of the glucose metabolism [34, 118, 119]. Intracellular 
glucose is subsequently phosphorylated to glucose-6-phosphate (G6P) by the 
enzyme hexokinase (HK). Glucose-6-phosphate serves as the substrate into differ-
ent pathways, including glycolysis, glycogen synthesis, and the pentose phosphate 
pathway (PPP) [34, 118, 119]. Glycolysis breaks down glucose to pyruvate to 
generate small amount of ATP and NADH [34, 118, 119]. The pyruvate is then 
transported into mitochondria for oxidation and energy production. Under hypoxia 
condition, pyruvate is disposed in the form of lactate [34, 118, 119].
Early study indicates that glucose and its metabolites contribute to the brown 
adipocyte thermogenesis by showing that catecholamine-induced glucose uptake 
was decreased when mitochondrial β-oxidation was inhibited in brown adipocytes 
[120]. Other studies in brown adipocyte glucose transportation also indicate the 
importance of the glucose in brown adipocyte metabolism [6, 112, 121, 122]. Both 
glucose transporter 1 (Glut1) and glucose transporter 4 (Glut4) are abundantly 
expressed in brown adipocytes and the insulin sensitive Glut4 is the major isoform 
[112, 122]. The in vitro study showed that knock-down of Glut1 and/or Glut4 gene in 
cultured brown adipocytes impaired the catecholamine-induced cell oxygen con-
sumption by 30–50% [6, 121]. Other studies indicate the importance of glycolysis 
in brown adipocyte thermogenesis [115, 123, 124]. An in vitro study showed that the 
knockdown of two glycolysis enzymes, HK2 or pyruvate kinase M (PKM), decreased 
glucose uptake and catecholamine-induced cell oxygen consumption by 67% or 
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34% respectively, in brown adipocytes [6]. These studies suggested the importance 
of glucose metabolism in brown adipocyte function. However, another detailed 
study indicated that glucose oxidation does not play a major role in brown adipocyte 
metabolism and thermogenesis, by showing that the rate of 14CO2 formation from the 
14C glucose was relatively small compared with the maximum rate of oxygen con-
sumption in activated brown adipocytes [125]. Studies using radio-labeled glucose 
also suggested that glucose uptake was only sufficient to fuel maximally ~15% of the 
thermogenic capacity in activated rodent brown adipocytes, suggesting that the sig-
nificantly upregulated glucose uptake in activated brown adipocytes is disassociated 
with the relative low glucose-mediated thermogenic capacity [123, 125, 126]. A more 
recent study indicates that the brown adipocyte energy production from glucose 
depends on the state of the cell: glucose and fatty acid contribute equally to brown 
adipocyte oxygen consumption under the basal condition; upon catecholamine-
activation, oxygen consumption is mainly fueled by fatty acids [6].
The dissociation between high glucose uptake and low glucose-mediated 
thermogenesis in activated BAT raises an important question: what is the function 
of the intracellular glucose in brown adipocytes? The importance of glucose in 
the de novo lipogenesis in brown adipocytes has been reported [127–129]. Studies 
indicate that glucose uptake is an independent process of thermogenesis in both 
cold-challenged and catecholamine-activated BAT, which further supports that 
glucose uptake might play other role as energy substrate in activated brown adipo-
cytes [116, 117, 130–132]. One detailed in vitro study using rat brown adipocytes 
showed that norepinephrine significantly enhanced glucose oxidation by sevenfold, 
while it also inhibited lipogenesis at the same time. On the other hand, insulin 
stimulation increased the lipogenesis by sevenfold in brown adipocytes whereas 
glucose oxidation remained very low. Most interestingly, the addition of insulin to 
the norepinephrine only potentiated the enhanced glucose oxidation, but do not 
enhance the lipogenesis [115]. On the other hand, another study showed that brown 
adipocytes converted a greater proportion of metabolized glucose into lactate and 
pyruvate, but only a smaller proportion into fatty acids through insulin-mediated 
pathway [125]. These studies suggest that glucose metabolism is involved in two dif-
ferent states in brown adipocytes, the thermogenic state and nonthermogenic state. 
It is plausible that during the thermogenic state, glucose contributes to both the 
energy production and lipogenesis; and during the nonthermogenic state, glucose 
contributes mainly to the lipogenesis and energy storage process in brown adipo-
cytes, which explains the disassociation of glucose uptake and glucose metabolism 
in brown adipocytes. In addition to glucose, other energy substrates, including 
glycerol and amino acid (glutamate), might also contribute to BAT metabolism 
and thermogenesis in human and rodent brown adipocytes. However, the relative 
contribution and partition of these energy substrates are unclear [132–135].
4. Energy storage in BAT
The cold challenge not only enhances catabolic processes mediating energy sub-
strate metabolism and heat generation, but also induces anabolic processes mediat-
ing fatty acid synthesis and lipogenesis, as well as glycogenesis [36, 111, 136–139].
Glucose can be stored as glycogen in brown adipocytes [36, 139]. Studies showed 
that glycogen synthases (GStot) and uridine diphosphate glucose pyrophospho-
rylase (Udgp), which mediates glycogenesis, were upregulated upon the cold 
challenge in BAT [36, 139]. Interestingly, glycogen hydrolysis enzyme, glycogen 
phosphorylase (Pygl), was also upregulated after cold challenge [36]. Although 
cold-challenge upregulates both glycogen synthesis and degradation, it is reported 
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that the stored glycogen is used up shortly after the cold challenge [139]. Indicating 
that glycogen is not an efficient format for energy storage and a sustainable energy 
resource in brown adipocytes.
The glucose uptaken by brown adipocyte can also be converted to fatty acid 
through the de novo lipogenesis. Carbohydrate response element-binding protein 
(ChREBP) is the major transcription factor mediating fatty acid synthesis in adi-
pocytes. There are two isoforms of ChREBP, ChREBPα and ChREBPβ. ChREBPα is 
abundantly expressed in BAT from rodents and humans [137, 140, 141]. De novo lipo-
genesis involves a series of enzymes mediating the sequential reactions converting 
glucose-derived citrate into fatty acids, including ATP-citrate lyase (ACLY), acetyl-
CoA carboxylases 1 (ACC1), fatty acid synthase (FASN), and stearoyl-CoA desatu-
rase-1 (SCD1). ChREBPα, coordinates with another transcription factor Max-like 
protein (MLX), directly binds to the carbohydrate response elements (ChoRE) and 
upregulates these de novo lipogenic genes expressions. ChREBPα can also increase 
the expression of ChREBPβ to further activate the de novo lipogenesis enzymes 
[142, 143]. It has been reported that lipogenic genes and AKT2-ChREBP pathways 
are upregulated to optimize fuel storage and thermogenesis upon cold stimulation 
in BAT [136]. In accordance with these studies, ChREBP−/− mice presented less BAT 
weight [142], and adipose-specific ChREBP-knockout mice had decreased carbohy-
drate-induced lipogenesis in BAT [144]. These studies indicate that ChREBP plays 
important roles in brown adipocyte’s de novo lipogenesis and energy storage.
Sterol regulatory element-binding protein-1 (SREBP-1) is another transcrip-
tion factor mediating the de novo lipogenesis [145]. Of the three different SREBP 
isoforms, SREBP1c is more abundant and SREBP1a is less abundant in the adipose 
tissue [137, 145, 146]. In vitro study showed that SREBP1c is sufficient to regulate 
lipogenic enzymes in cultured adipocytes [147]. In the adipose-specific ap2-
SREBP1c transgenic mice, lipogenic enzyme Acc1, FASN and Scd1 expression as 
well as fatty acids synthesis rate were significantly upregulated in brown adipocytes 
[148]. In line with this study, ap2-SREBP1a transgenic mice also developed adipose 
tissue hypertrophy in accordance with an increased lipogenic enzyme profile and 
enhance de novo lipogenesis in the BAT [148]. However, some in vivo studies indi-
cated that SREBP1c’s role in the de novo lipogenesis in adipocytes is dispensable, as 
evidenced by SREBP1-knockout mice have normal lipogenic enzymes gene expres-
sion profile and normal lipid storage in their adipose tissue [149, 150]. These studies 
suggest that SREBP-1 is involved in the brown adipocyte lipogenesis and triglycer-
ide storage when the excessive energy resources are available; however, SREBP-1’s 
function can be compensated by other factors when it is absent.
In summary, these studies suggest that in activated brown adipocytes, glyco-
genesis and lipogenesis are upregulated to store/restore energy substrates, which is 
parallel with energy substrate metabolism and thermogenesis. These coordinated 
anabolic and catabolic processes are important to maintain the brown adipocyte 
energy homeostasis.
5. The proceeding of targeting BAT in human metabolic disorders
The understating of BAT energy homeostasis and the discovery of the functional 
BAT in humans lead to significant interests in targeting BAT for metabolic disorders, 
for example, obesity, insulin resistance, type 2 diabetes, and lipid profile abnormal-
ity. The ability of BAT metabolizing fatty acid and glucose from the intracellular 
storage, the peripheral tissues liberation, and teh dietary nutrition absorption makes 
it a good potential therapeutic target for combating metabolic disorders in humans. 
In addition to the BAT, beige/brite fat, which is coexisted in white adipose tissue, 
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can be recruited and activated (browning) in respond to cold challenge or pharma-
cological stimulation and serves as a target for metabolic disorders [151–154].
It has been reported that the BAT 18F-FDG uptake in humans correlates inversely 
with aging, adiposity, diabetic status, and BMI, indicating that the manipulation of 
BAT function is a possible approach for combating metabolic disorders [8–14, 16, 
21–24, 155, 156]. The studies in mouse models and humans provide evidences for the 
metabolic benefit of BAT. Mice with genetic ablation of BAT and the UCP1-knockout 
mice under thermoneutrality, both developed obesity [18–20, 85]. In addition, BAT 
activation reduced hypercholesterolemia and protected mice from atherosclerosis 
development and liver steatosis [18–20, 85]. It is well-recognized that BAT can be 
activated upon seasonal temperature changes or short time period (several hours) 
mild cold challenge (16-19°C) in humans [7, 9, 10, 12, 21, 22, 24–27, 157]. However, 
the significance of BAT’s contribution in human metabolism has not been clearly 
elucidated. Human studies indicated that BAT activity is inversely correlated with 
body fat deposition, suggests BAT can serve as a target for obesity [9, 10, 16, 21–24]. 
Studies also showed that fasting glucose was lower in the human subjects with 
higher BAT prevalence and the BAT activity were blunted in subjects with obesity 
[11, 16, 155]. More interestingly, in the same patients with multiple PET scans, BAT 
was more detectable when fasting glucose in the subjects were lower [16]. Other 
studies showed that a mild cold challenge significantly increased whole body glu-
cose disposal, glucose oxidation, insulin sensitivity, and whole body energy expen-
diture in human subjects [13, 17, 158, 159]. Additional study showed that moderate 
cold challenge (18.06°C) significantly improved the peripheral glucose uptake 
and insulin sensitivity by 20%, but did not impact the pancreatic insulin secretion 
[17]. These studies strongly indicate the therapeutic potentials of targeting BAT for 
glucose metabolism in humans, but leave the question of the relative contribution of 
activated BAT in whole body glucose metabolism to be answered.
Cold challenge can also enhance BAT lipid metabolism. Studies showed that 
cold challenge led to significantly enhanced lipid mobilization, increased plasma 
fatty acid levels, as well as upregulated genes for lipid metabolism in human BAT 
[12, 58, 156, 160]. It is reported that circulating fatty acids were uptaken by BAT 
in cold-challenged humans by using the 18FTHA tracing method [88]. In addi-
tion, it has been shown that cold-activated BAT significantly contributed to whole 
body fatty acid utilization in healthy humans [17]. The fatty acid uptake is sig-
nificantly lower in overweight human subjects compare to healthy humans [156]. 
Importantly, BAT activation upon mild cold challenge significantly increased 
systemic lipid metabolism, whole body lipolysis, triglyceride-fatty acid cycling, 
and fatty acid oxidation in overweight/obese subjects [14]. These studies suggest 
that BAT contributes to whole body lipid metabolism and homeostasis in healthy 
humans as well as in humans with metabolic disorders, suggesting that BAT can 
serve as a target for lipid abnormality in humans.
The significance of BAT/beige adipose tissue in human whole body metabolism 
has been studied and remarkable progress has been made in recent years. The 
acknowledgment that BAT can be activated and subsequently contributes to the 
human whole body energy expenditure is encouraging. Although the capacity and 
relative significance of BAT’s contribution to whole body energy substrate metabo-
lism has not been elucidated, it should be noticed that majority of the studies in 
humans were conducted for relative short time period with mild cold challenge 
conditions. Given, humans usually live under thermoneutrality, we can assume that 
their BAT functions are repressed under this condition. In addition, the prevalence 
of BAT in humans varies significantly, which depends on individual’s life style, 
physical activity, and health conditions, which makes it harder to evaluate the 
contribution of BAT in whole body metabolism [7, 9–12, 21, 22, 24–27, 88, 156, 157]. 
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Hence, a sustainable chronic mild cold challenge strategy aiming to recruit more 
BAT/beige adipose tissue and enhance their oxidative capacity might provide 
more significant therapeutic potential in humans over time, especially the human 
subjects with metabolic disorders. Future studies should also delineate the relative 
contribution from glucose and fatty acid in human BAT under physiological and 
pathological conditions; as well as compare the glucose and fatty acid partitioning 
in different tissues and organs, including skeletal muscle, heart, liver and BAT. 
These details will guide us to establish better strategies targeting metabolic disor-
ders through BAT activation in the future.
6. Conclusion
The energy metabolism plays critical role in maintaining BAT thermogenic 
function in mammals. Through the energy metabolism, the chemical energy stored 
in nutrients (i.e., fatty acids and glucose) can be converted to thermoenergy and 
dissipated as heat in the BAT. Activated brown adipocytes not only contribute to the 
intracellular substrate homeostasis, but also contribute significantly to the whole 
body energy metabolism. BAT with functional thermoactivity is present in adult 
humans. Thus, BAT activation has remarkable therapeutic implications in human 
metabolic disorder management.
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